Stephen Hoge - Feb 12, 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
President
Signature
/s/ James Dillon, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Feb 12, 2025
Transactions value $
-$85,707
Form type
4
Date filed
2/14/2025, 04:12 PM
Previous filing
Feb 10, 2025
Next filing
Feb 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Award $0 +5.73K +0.4% $0.00 1.45M Feb 12, 2025 Direct F1
transaction MRNA Common Stock Tax liability -$85.7K -2.77K -0.19% $30.93 1.45M Feb 12, 2025 Direct F2
holding MRNA Common Stock 4.12K Feb 12, 2025 By Valhalla, LLC
holding MRNA Common Stock 152K Feb 12, 2025 By Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction is the vesting of performance-based restricted stock units granted to the reporting person on March 1, 2022 (the "2022 PSUs").
F2 Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vesting of the 2022 PSUs.
F3 These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.